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Background: Obesity is a potentially modifiable risk fac-
tor for the development and progression of kidney disease, 
both in adults and children. We aim to study the association of 
obesity and renal function in children, by comparing estimated 
glomerular filtration rate (eGFR) in nonoverweight and over-
weight/obese children. Secondarily, we aim to evaluate the 
accuracy of equations on eGFR estimation when compared to 
24-h urinary creatinine clearance (CrCl).
Methods: Cross-sectional study of 313 children aged 
8–9 y, followed in the birth cohort Generation XXI (Portugal). 
Creatinine and cystatin C, GFR estimated by several formulas 
and CrCl were compared in 163 nonoverweight and 150 over-
weight/obese, according to World Health Organization growth 
reference.
results: Overweight/obese children had significantly lower 
eGFR, estimated by all methods, except for CrCl and revised 
Schwartz formula. Despite all children having renal function 
in the normal range, eGFR decreased significantly with BMI 
z-score (differences ranging from −4.3 to −1.1 ml/min/1.73 m2 
per standard deviation of BMI). The Zappitelli combined for-
mula presented the closest performance to CrCl, with higher 
correlation coefficients and higher accuracy values.
conclusion: Young prepubertal children with overweight/
obesity already present significantly lower GFR estimations 
that likely represent some degree of renal impairment associ-
ated with the complex deleterious effects of adiposity.
the role of the obesity epidemic in the risk of kidney disease has been recognized in adults, independently of diabetes, 
with the prevalence of end-stage renal disease raising tremen-
dously in the past 3 decades in parallel with the increased prev-
alence of obesity (1,2). Obesity was also identified as a strong 
and potentially modifiable risk factor for the development and 
progression of kidney disease (3,4) and, in children, recent 
data confirmed a similar trend, with obesity contributing to 
renal injury and to an important increase of chronic kidney 
disease (5).
Studies in the general pediatric population only recently 
started to arise and the results concerning glomerular filtration 
rate (eGFR) differences in obese and normal weight children are 
somehow contradictory; some studies reported higher eGFR in 
obese children reflecting a state of hyperfiltration (6), while oth-
ers found either the opposite (7,8) or no differences (9,10).
It is difficult to evaluate renal function in the general pedi-
atric population and to which extent the kidney is involved in 
the metabolic cluster of conditions that emerge with the onset 
of obesity in early ages. On the one hand, since exogenous 
and more accurate, but invasive, methods are not justifiable to 
apply in healthy children, one has to rely on eGFR formulas or 
in the 24-h urine creatinine clearance (CrCl). However, for-
mulas to estimate eGFR are known to have some limitations 
and 24-h urine samples might be difficult to reliably obtain in 
children (11). On the other hand, the degree of kidney involve-
ment related to obesity might be subtle, below the threshold 
to translate into changes in classic markers. The emergence of 
cystatin C (CysC) was expected to overcome some of the limi-
tations of creatinine-based estimations, adding an improved 
clinical sensitivity in early renal damage (12). Though, stud-
ies in adults showed that CysC levels are increased in obese 
subjects (13,14) and that CysC-based formulas may result in 
an underestimation of GFR in patients with higher BMI (15). 
Few studies exist on CysC levels in children, leaving a large 
uncertainty regarding the influence of body composition in 
the interpretation of CysC levels (16).
Our main objective was to compare renal function between 
nonoverweight and overweight/obese 8–9-y-old children, 
assessed by serum creatinine and CysC, and eGFR, esti-
mated by creatinine-based, CysC-based and combined for-
mulas (including both creatinine and CysC) and by CrCl. 
Secondarily, we aimed to clarify if putative differences in renal 
function between groups reflect alterations in the kidney or are 
solely determined by nonrenal differences in direct association 
with body composition. We also aimed to evaluate the accu-
racy of selected equations of eGFR estimation when compared 
to CrCl, in nonoverweight and overweight/obese children.
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RESULTS
A total of 313 children (53% male) with a mean (SD) age of 
8.8 (0.2) y were included in the present analysis. Clinical char-
acteristics and levels of biochemical parameters of all study 
subjects and separately for nonoverweight (n = 163) and over-
weight/obese children (n = 150, of whom 89 overweight and 
61 obese) are shown in Table 1. The overweight/obese group 
presented higher blood pressure values and both systolic and 
diastolic blood pressure were significantly correlated with BMI 
z-score (r = 0.375, P < 0.001 and r = 0.162, P < 0.001, respec-
tively) and with waist-to-height ratio (WHtR) (r = 0.315, P < 
0.001 and r = 0.139, P = 0.014, respectively). Comparing renal 
function between the groups, both creatinine and CysC were 
significantly higher in the overweight/obese group. Depending 
on the method of estimation, the mean eGFR ranged from 113 
to 162 in nonoverweight children and from 110 to 156 ml/
min/1.73 m2 in overweight/obese children, with overweight/
obese children presenting significantly lower eGFR when esti-
mated by all methods, except for CrCl and Schwartz-R formula 
(Table 1). No significant differences were found in the 24-h 
urine albumin or protein excretion.
All children had renal function markers and estimated 
eGFR in the normal range (at or above 90 ml/min/1.73 m2). 
Significant positive correlations were found between BMI 
z-score and both creatinine (r = 0.18, P = 0.002) and CysC 
(r = 0.29, P < 0.001). Significant negative correlations were 
found between BMI z-score and estimations of eGFR, except 
for Schwartz-R. The strongest correlations were observed with 
the CysC-based equation (r = −0.30, P < 0.001), followed by 
Zappitelli-Comb formula (r = −0.22, P < 0.001; Figure 1). In 
the age- and sex-adjusted linear regression analysis of markers 
of renal function on BMI z-score (Table 2), eGFR decreased 
significantly with BMI (except for Schwartz-R), with differ-
ences for the several methods ranging from −4.26 to −1.10 ml/
min/1.73 m2 per SD of BMI (1 SD BMI z-score is ~1.2 kg/m2 
for girls and boys at this age).
Since significant differences in eGFR between nonover-
weight and overweight/obese children were observed for all 
estimations including CysC, and considering that obesity 
might be a nonrenal determinant of CysC, we quantified the 
independent association of CysC with BMI z-score and the 
creatinine-based methods to assess renal function. Both BMI 
table 1. General characteristics, renal function markers, and estimated glomerular filtration rates of the nonoverweight and overweight/obesity 
groups
All
WHO BMI z-score classification
P
Nonoverweight Overweight/obesity
n = 313 n = 163 n = 150
Age (months) 105 ± 3 105 ± 3 105 ± 3 0.300
Male sex 166 (53%) 83 (51%) 83 (55%) 0.434
BMI z-score 0.95 ± 1.24 −0.03 ± 0.74 2.00 ± 0.66 <0.001
WHtR (cm/m) 49 ± 6 45 ± 3 53 ± 5 <0.001
% body fat mass 17 ± 11 10 ± 7 23 ± 9 <0.001
Occasional systolic blood pressure (mmHg) 103 ± 9 101 ± 9 106 ± 8 <0.001
Occasional diastolic blood pressure (mmHg) 65 ± 7 64 ± 7 66 ± 7 0.021
Total cholesterol (mg/dl) 159 ± 26 156 ± 25 162 ± 27 0.045
HDL cholesterol (mg/dl) 54 ± 10 55 ± 11 53 ± 10 0.152
Triglycerides (mg/dl) 59 ± 27 53 ± 20 65 ± 31 <0.001
Fasting glucose (mg/dl) 86 ± 5 86 ± 5 86 ± 5 0.455
HOMA-IR 1.28 (0.97–1.76) 1.12 (0.84–1.39) 1.50 (1.15–2.08) <0.001
Uric acid (mg/dl) 3.65 ± 0.73 3.47 ± 0.67 3.85 ± 0.75 <0.001
Serum creatinine (mg/dl) 0.44 ± 0.06 0.43 ± 0.06 0.45 ± 0.06 0.001
Serum cystatin C (mg/l) 0.66 ± 0.07 0.64 ± 0.07 0.68 ± 0.07 <0.001
eGFR—Schwartz-R (ml/min/1.73 m2) 128 ± 18 129 ± 19 127 ± 17 0.241
eGFR—Filler (ml/min/1.73 m2) 148 ± 17 152 ± 17 144 ± 17 <0.001
eGFR—Zappitelli-Comb (ml/min/1.73 m2) 135 ± 16 138 ± 16 132 ± 15 <0.001
eGFR—Schwartz-Comb (ml/min/1.73 m2) 111 ± 11 113 ± 11 110 ± 11 0.021
24-h creatinine clearance (ml/min/1.73 m2) 159 ± 32 162 ± 34 156 ± 30 0.092
The values presented are mean ± SD, median (25th-75th percentiles) or n (%).The nonoverweight group includes children with thinness and normal weight and the overweight/
obesity group includes children with overweight or obesity, according to the WHO classification for BMI z-score (19). Data regarding 24-h creatinine clearance refers only to 298 cases 
with valid 24-h urine samples.
eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; WHO, World Health Organization; WHtR, waist-to-height ratio.
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z-score and eGFR (by Schwartz-R formula or CrCl) were inde-
pendent determinants of CysC (Table 3).
In Table 4, we summarize the agreement between dif-
ferent formulas to estimate eGFR and CrCl. The formula 
that seemed to have the closest performance to CrCl (both 
higher correlation coefficients and higher accuracy values) 
and to present the most similar results in the nonover-
weight and overweight/obesity groups was the Zappitelli-
Comb. The Bland-Altman plots for each formula, using 
CrCl as the reference eGFR value, for nonoverweight and 
overweight/obesity groups, are presented in Figures 2 and 
3, respectively.
DISCUSSION
In our study of healthy prepubertal children, significant 
inverse correlations were found between renal function and 
BMI z-score, with eGFR decreasing significantly with BMI, 
despite all children having renal function in the normal range. 
Overweight and obese children had significantly higher levels 
of both creatinine and CysC and lower eGFR values.
Figure 1. Scatter plots of renal function markers on BMI z-score. Pannels a to g depict scatter plots of renal function markers on BMI z-score: 
(a) Creatinine (mg/dl); (b) Cystatin C (mg/l); (c) Revised Schwartz formula (ml/min/1.73 m2); (d) Filler formula (ml/min/1.73 m2); (e) Zappitelli combined 
formula (ml/min/1.73 m2); (f) Schwartz combined formula (ml/min/1.73 m2); (g) 24-h creatinine clearance (ml/min/1.73 m2). Data shown are Pearson 
 correlation coefficients (r). Regarding 24-h creatinine clearance analysis, only 298 cases with valid 24-h urine samples were included. *P < 0.050;  
**P < 0.010; †P < 0.001.
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Renal impairment in association with obesity in children is 
still a debated question and contradictory results continue to 
emerge. It is well established that in the first stages of renal 
dysfunction associated with obesity, hyperfiltration occurs 
as a physiological adaptation of the kidney to the increased 
body mass (17,18). Concordantly, some authors reported 
strong positive correlations between measures of obesity and 
renal eGFR (6), while others did not observe any differences 
in eGFR levels between overweight/obese and nonoverweight 
children (9,10). In our sample of young prepubertal children, 
actually, we found that obesity was associated with lower 
renal function. Our findings may result from the fact that we 
had a larger sample of both overweight/obese and nonover-
weight children than most of the studies cited. The variation of 
body composition and eGFR with growth is a major concern 
in studies that include an age-wide sample; not only did we 
study a narrow age interval, but also models were adjusted for 
age (in months). Besides, it is noteworthy that in our sample 
most of the children in the overweight/obesity group (about 
60%) already presented overweight or obesity at the age of 4; 
thus longer times of exposure might implicate more advanced 
stages of obesity-related renal injury, with measurable dif-
ferences in renal function markers becoming more appar-
ent. At this point we cannot ascertain if a previous phase of 
hyperfiltration occurred in the initial phases of renal adapta-
tion to higher body fat mass in our sample. Similarly to our 
results, other authors in large representative population-based 
cohort studies found lower renal function estimations in obese 
children (7,8). A large population-based study of adolescents 
in the United States found significantly lower mean eGFR lev-
els in obese subjects, but the authors considered that obesity 
did not play a significant role in changing the eGFR distribu-
tion in the entire study population (19). The possible mecha-
nisms through which obesity might cause renal impairment in 
young children are diverse. Obesity-related kidney damage is 
thought to initiate with a hyperfiltration phase, as previously 
stated, that later potentiates progressive renal damage, with 
increased loss of proteins and a last phase of glomerulomegaly, 
cellular remodeling, and fibrotic scaring (20). More recently, 
the recognition that adipose tissue is involved in the produc-
tion of several bioactive molecules, such as adiponectin, leptin, 
inflammatory, and oxidative stress markers, even in children 
(21,22), and that many of those substances may affect the cells 
in the renal glomeruli and cause pathological changes has been 
an important focus of research (20). It has been speculated that 
the production of active fibrotic cytokines recognized in sev-
eral kidney diseases as markers of disease activity and histo-
pathological deterioration, might also be increased in the set 
of obesity (23). Such substances were shown to be increased 
in children with congenital single kidney in comparison with 
controls, even in early phases of hyperfiltration when protein-
uria and renal insufficiency are still absent (24). Since kidney 
diseases with reduced renal mass are believed to mimic what 
happens in obesity, representing the clinical translation of the 
experimental hyperfiltration models (25), the increased levels 
of these substances, promoted in the proinflammatory and 
pro-oxidant setting of obesity, might partially explain the kid-
ney impairment observed. Moreover, it is important to recog-
nize that some of the conditions associated with obesity might 
also act to reduce renal function, such as high blood pressure 
(and glomerular hypertension), hyperlipidemia, insulin resis-
tance, hyperleptinemia and increased sympathetic activity and 
overactivation of renin-angiotensin system (2,26). Another 
factor contributing to explain the impact of obesity on the kid-
ney might be the reduced nephron mass associated with condi-
tions like being born small for gestational age or preterm (27). 
These children are at higher risk of becoming obese, due to 
prenatal programming, and since the nephron number is fixed 
at birth, weight gain will increase the metabolic and hemody-
namic load on each individual nephron and might contribute 
to more rapid renal deterioration (25).
We reported that the differences in CysC levels were not 
exclusively attributable to nonrenal differences, perchance 
directly related to differences in the body fat mass. Thus, the 
table 3. Mean change in serum cystatin C (mg/l), per unit of BMI 
z-score, and renal function (assessed either by revised Schwartz 
formula or 24-h creatinine clearance)
Serum cystatin C (mg/l)
β (95% CI) P
Model 1
BMI z-score 0.016 (0.010 to 0.022) <0.001
eGFR Schwartz-R (ml/min/1.73 m2) −0.001 (−0.001 to −0.001) <0.001
Model 2
BMI z-score 0.017 (0.010 to 0.023) <0.001
CrCl (ml/min/1.73 m2) −0.000 (−0.001 to −0.000) 0.001
The values presented are β and 95% confidence intervals, estimated by multiple 
linear regression, adjusting for sex and age in months, beyond the mutual adjustment 
between the two independent variables shown in each model. In the model with 24-h 
creatinine clearance only 298 cases with valid 24-h urine samples were included.
table 2. Mean changes in renal function markers and estimated glomerular filtration rates per unit of BMI z-score
Creatinine  
(mg/dl)
Cystatin C  
(mg/l)
eGFR Schwartz-R  
(ml/min/1.73m2)
eGFR Filler  
(ml/min/1.73m2)
eGFR  
Zappitelli-Comb  
(ml/min/1.73m2)
eGFR Schwartz-
Comb  
(ml/min/1.73m2)
CrCl  
(ml/min/1.73 m2)
BMI 
z-score
0.007  
(0.002 to 0.013); 
 P = 0.004
0.017  
(0.011 to 0.023); 
 P < 0.001
−0.51  
(−2.17 to 1.16);  
P = 0.548
−4.26  
(−5.77 to −2.74); 
 P < 0.001
−2.77  
(−4.16 to −1.38);  
P < 0.001
−1.10  
(−2.01 to −0.18);  
P = 0.014
−3.54  
(−6.52 to −0.57);  
P = 0.020
The values presented are β and 95% confidence intervals, estimated by multiple linear regression, with renal function markers as dependent variable and BMI z-score (continuous) as 
independent variable, adjusting for sex and age in months. In the model with 24-h creatinine clearance only 298 cases with valid 24-h urine samples were included.
eGFR, estimated glomerular filtration rate.
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findings of lower renal function estimations in overweight/
obese children likely represent some degree of renal impair-
ment in relation with obesity, already at such a young age. The 
pertinence of this remark arises from the fact that, although 
CysC emerged as an alternative filtration marker less affected 
by muscle mass and diet and more sensitive in early phases of 
renal impairment than creatinine, its levels might be affected 
by nonrenal determinants, such as body fat (13–15). There 
are a limited number of studies on CysC levels in overweight 
and obese children. Our results are in disagreement with the 
results from the study by Codoñer-Franch et al. (16), which 
reports that while CysC associates with several cardiovascular 
risk factors, the increased CysC levels could not be attributed 
to altered renal function, as evaluated by eGFR. In order to 
clarify the body composition interference in the levels of CysC, 
the indirect estimations of renal function need to be compared 
with exact eGFR determinations by exogenous methods and, 
to our knowledge, such a study does not exist in the general 
pediatric population.
Although recognizing the lack of a solid reference stan-
dard for eGFR in our study, we compared a selection of cre-
atinine- and CysC-based and combined equations with the 
CrCl, aiming to better understand their differences in relation 
with body composition. Several studies in children reported 
eGFR formulas to be reliable methods to assess kidney func-
tion (28,29) but the accuracy of CrCl is rarely reported. Since 
endogenous creatinine clearance has been widely used and 
is still a frequent proxy used in clinical practice to estimate 
eGFR, we decided to use it as our reference standard. It has 
long been recognized that CrCl can be affected by inaccura-
cies in the quantity of urine collected and that tubular secre-
tion of creatinine falsely elevates the eGFR estimation (30). 
It is important to emphasize that on top of a strict protocol 
for field work, we carefully assessed the quality of 24-h urine 
samples, excluding 5% of our samples. We found that, both in 
nonoverweight and overweight/obese children, eGFR estima-
tion using Zappitelli-Comb formula revealed to be the closest 
to the CrCl. A recent study in adults addressed the issue of 
possible differential performances of eGFR equations, either 
including creatinine, CysC or both, in subgroups defined by 
body composition (31). The authors reported that, in compari-
son with exogenous methods for eGFR determination, both 
creatinine- and CysC-based equations underestimated eGFR 
in people with higher BMI and that the higher absolute differ-
ences were found in people with normal renal function (eGFR 
> 90 ml/min/1.73 m2). The absolute differences and bias among 
subgroups were smallest for combined equations and the 
authors advocated towards the preferential use of combined 
table 4. Accuracy and bias of different formulas for glomerular filtration rate estimation compared to 24-h creatinine clearance, in 
nonoverweight and overweight/obese children (24-h creatinine clearance (mean ± SD)—nonoverweight: 162 ± 34 ml/min/1.73 m2; overweight/
obese: 156 ± 30 ml/min/1.73 m2)
Equations using either serum creatinine or serum cystatin C
Filler Schwartz-R
Nonoverweight Overweight/obesity Nonoverweight Overweight/obesity
eGFR (ml/min/1.73 m2), mean ± SD 152 ± 17 143 ± 17* 129 ± 19* 127 ± 17*
CrCl—eGFR (ml/min/1.73 m2),  
mean ± SD
9.5 ± 36.1 12.3 ± 29.6 32.7 ± 27.1 29.1 ± 26.5
Accuracy 10% (%) 39.6 38.9 17.5 23.6
Accuracy 30% (%) 87.7 90.3 79.2 81.9
Accuracy 50% (%) 95.5 97.9 100.0 100.0
Correlation coefficient between eGFR 
and CrCl
0.148 0.288** 0.622** 0.469**
Equations using both serum creatinine and CysC
Zappitelli-Comb Schwartz-Comb
Nonoverweight Overweight/obesity Nonoverweight Overweight/obesity
eGFR (ml/min/1.73 m2), mean ± SD 139 ± 16* 132 ± 15* 113 ± 11* 110 ± 11*
CrCl—eGFR (ml/min/1.7 3m2),  
mean ± SD
23.1 ± 29.7 23.7 ± 26.1 49.0 ± 31.5 45.9 ± 27.9
Accuracy 10% (%) 31.8 30.6 8.4 10.4
Accuracy 30% (%) 87.0 87.5 51.9 49.3
Accuracy 50% (%) 99.4 100.0 97.4 98.6
Correlation coefficient between  
eGFR and CrCl
0.509** 0.478** 0.417** 0.345**
In the agreement analysis, only 298 cases with valid 24-h urine samples were included. The nonoverweight group includes children with thinness and normal weight and the 
overweight/obesity group includes children with overweight or obesity, according to the World Health Organization classification for BMI z-score (19). *P < 0.001, Paired t-test in 
comparison with 24-h creatinine clearance. **P < 0.001, Pearson correlation.
eGFR, estimated glomerular filtration rate.
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formulas. These findings are in line with studies that found a 
good agreement of Zappitelli-Comb formula and exogenous 
eGFR determinations (28,29) and are concordant with the rec-
ommendation to prefer combined formulas, especially in sub-
groups in which body composition might interfere (31). The 
use of creatinine and CysC in combination seems to result in 
improved accuracy, with the effects of the non-GFR determi-
nants of each marker being more attenuated than when using 
each one alone. In conclusion, the use of combined formulas 
to estimate eGFR might represent a valid alternative to the 
lengthy and difficult collection of 24-h urine in children, both 
in nonoverweight and overweight/obese children.
The major strength of our study is the large sample of over-
weight and obese children, otherwise healthy, with very com-
plete data on cardiovascular and renal markers, allowing an 
extensive and thorough analysis. The lack of repeated mea-
surements of kidney function might be a limitation to puta-
tively reduce short-term fluctuations due to external factors, 
but we believe that this was, at least, partly overcome by the use 
of multiple methods for renal function assessment. Besides, we 
selected eGFR formulas taking into account the laboratory 
methods for renal markers determination used in our cen-
ter and used in the validation of each formula, thus reducing 
the systematic bias between the methods and allowing com-
parisons. Serum creatinine was determined by the Jaffé com-
pensated technique but calibrated according to international 
parameters (32), thus allowing comparison with formulas 
that used creatinine measured by an enzymatic assay, such as 
Schwartz-R, Zappitelli-Comb, and Schwartz-Comb. The com-
parison of several methods in overweight/obese and nonover-
weight children is of major interest, since in clinical practice, 
when observing healthy children, we need to be able to decide 
which method might be reliably used across all groups of body 
composition. Apparently the 24-h urine collection might be 
dispensable if both creatinine and CysC levels are available.
We acknowledge some limitations in our study. First, an 
exogenous method would be important when aiming to deter-
mine the accuracies of indirect measurements of renal func-
tion and to definitely characterize the degree of actual renal 
impairment in overweight/obese subjects with higher CysC 
levels. Second, the cross-sectional design of the present anal-
ysis, along with the fact that renal injury markers should be 
Figure 2. Bland-Altman plots of the different formulas for glomerular filtration rate estimation in comparison with 24-h urine creatinine clearance, for 
nonoverweight subjects. Pannels a to d depict Bland-Altman plots of the different formulas for glomerular filtration rate estimation in comparison with 
24-h urine creatinine clearance, for nonoverweight subjects: (a) Revised Schwartz formula; (b) Filler formula; (c) Zappitelli combined formula; (d) Schwartz 
combined formula. In the agreement analysis, only 298 cases with valid 24-h urine samples were included. The horizontal full line represents the mean 
difference between 24-h creatinine clearance and eGFR, and the horizontal dashed lines the limits of agreement. The nonoverweight group includes 
children with normal weight, according to the World Health Organization classification for BMI z-score (35).
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investigated in the long-term, is also a limitation. Nevertheless, 
this limitation can be overcome in the future if, as intended, 
we follow these children through adulthood in order to better 
understand the real impact of obesity on their kidney function.
Conclusion
In conclusion, we report that young prepubertal children with 
overweight or obesity at the age of 8–9 y already present signifi-
cantly lower eGFR. We showed that CysC levels are increased in 
overweight/obese children and that this elevation most probably 
represents some degree of renal involvement in the complex net of 
deleterious effects associated with obesity. The association of obe-
sity with cardiovascular risk factors and lower eGFR levels alerts 
us to the fact that overweight and obese children are at risk for 
cardiovascular events and chronic kidney disease . Nevertheless, 
since our results focus on a very young age when all children still 
have normal renal function, one can expect to be able to reduce 
the burden of chronic kidney disease in the adult population if 
measures against obesity are implemented early in life.
METHODS
Study Design and Sample
We conducted a cross-sectional study of children aged 8–9 y that 
have been followed since birth in a previously established cohort 
study (Generation XXI) (33). Subjects from the original cohort were 
eligible for the present study protocol (ObiKid project) if they had 
anthropometric data and a blood sample withdrawn at the 7-y-old 
evaluation (n = 4,590). We aimed to include a minimum sample 
of 300 children for the Obikid project’s main objective; assuming 
that about 35% would be excluded due to refusal to participate, 
exclusion criteria or incomplete information, 463 children were 
preselected to be consecutively screened according to the date of 
their 7-y-old evaluation: 16 could not be contacted, 32 refused to 
participate, 23 were unable to schedule the study visits during the 
recruitment period, and 68 met exclusion criteria (4 chronic dis-
eases, 1 chronic usage of medication, 51 living far from the study 
site, and 12 twins). We finally enrolled 324 participants, between 
August 2013 and August 2014. For the present analysis, 11 children 
were additionally excluded due to absence of blood or 24-h urine 
samples and 313 children were finally included. This sample size 
would provide a statistical power of 86% to detect a difference in 
eGFR, between nonoverweight and overweight/obese children, of at 
least 8 ml/min/1.73 m2, assuming SD of 24 and 22 ml/min/1.73 m2 
in each group, respectively (7).
Figure 3. Bland-Altman plots of the different formulas for glomerular filtration rate estimation in comparison with 24-h urine creatinine clearance, for 
overweight/obese subjects. Pannels a to d depict Bland-Altman plots of the different formulas for glomerular filtration rate estimation in comparison 
with 24-h urine creatinine clearance, for overweight/obese subjects: (a) Revised Schwartz formula; (b) Filler formula; (c) Zappitelli combined formula; 
(d) Schwartz combined formula. In the agreement analysis, only 298 cases with valid 24-h urine samples were included. The horizontal full line represents 
the mean difference between 24-h creatinine clearance and eGFR, and the horizontal dashed lines the limits of agreement. The overweight/obese group 
includes children with overweight and obesity, according to the World Health Organization classification for BMI z-score (35).
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Data Collection and Variable Definition
The study visits took place at the Department of Clinical Epidemiology, 
Predictive Medicine and Public Health, Faculty of Medicine of the 
University of Porto. Anthropometric and general physical examina-
tions were performed, according to standard procedures and as previ-
ously reported (34). Waist circumference (measured at the umbilicus’ 
line) was indexed to height (WHtR in cm/m) for analysis. Body fat 
percentage was assessed by foot-to-foot bioelectrical impedance anal-
ysis (TBF-300 (Tanita, Arlington Heights, Illinois)). BMI was calcu-
lated and BMI-for-age values were classified according to the World 
Health Organization reference data for BMI z-score into the following 
categories: nonoverweight (≤+1 SD, including children with thinness 
(n = 1) and normal weight) and overweight/obesity (>1 SD, including 
children with overweight and obesity) (35).
Office blood pressure was evaluated with oscillometric validated 
sphygmomanometers (Elite 92125 (Medel, Parma, Italy)) with an 
adequately sized cuff in the right arm, by a nonphysician trained 
interviewer, three times with a 5-min interval, and the second and 
third measurements were averaged for analysis.
Laboratory Procedures
Venous blood samples were collected after an overnight fast of at least 
8 h and analyzed for creatinine, CysC, urea, glucose, insulin, and lip-
ids. Insulin resistance was determined using the homeostasis model 
assessment index (36). All participants collected a 24-h urine sample, 
which was analyzed for creatinine. All the standard laboratory ana-
lyzes were performed in the Clinical Pathology Department of Centro 
Hospitalar São João, Porto - Portugal.
Renal Function Parameters
Serum creatinine assay was based on the Jaffé compensated traceable 
to an isotope dilution mass spectrometry method (Olympus AU 5400 
analyzer (Beckman-Coulter, Brea, CA) (32). Urinary creatinine was 
determined with the same clinical chemistry analyzer. Serum CysC 
was assayed using a particle-enhanced immunonephelometric assay 
(N latex CysC (Siemens, Erlangen, Germany).
To estimate eGFR, in ml/min/1.73 m2, the following formulas were 
used: revised Schwartz formula (Schwartz-R), k × (height (cm)/serum 
creatinine (mg/dl)); using a k constant of 0.413) (30); Filler formula, 
Log(GFR) = 1.962 + (1.123 × log(1/cystatin C (mg/l)) (37); combined 
Zappitelli formula (Zappitelli-Comb), (507.76 × e0.003 × height(cm))/(cys-
tatin C (mg/l)0.635 × serum creatinine (mg/dl)0.547)) (38) and combined 
Schwartz formula (Schwartz-Comb), 39.8 × (height (cm)/serum 
creatinine (mg/dl))0.456 × (1.8/cystatin C (mg/l)0.418 × (30/blood urea 
nitrogen)0.079 × (height (cm)/1.4)0.179 (×1.076 if females)) (39).
All children’s parents received information on the correct meth-
ods of 24-h urine collection and, upon sample delivery, compliance 
was rechecked by a brief questionnaire. The samples were considered 
valid if urinary creatinine was within the range of 11.3–28.0 mg/kg/d 
(according to age- and sex-specific reference values (40)) and if uri-
nary volume was over 300 ml; based on these criteria, 15 urine samples 
were excluded from the analysis. The CrCl was calculated according 
to the standard formula and normalized to 1.73 m2 of body surface; 
body surface area was determined by the Haycock formula (41).
Ethics
The ObiKid project was approved by the Ethics Committee of Centro 
Hospitalar São João, Porto—Portugal and Faculty of Medicine of 
the University of Porto and complies with the Helsinki Declaration. 
Written informed consent from parents and verbal assent from chil-
dren was obtained, concerning information, and biological samples 
gathering.
Statistical Analysis
Standard statistical analysis was performed using IBM SPSS Statistics 
for Windows, Version 20.0 (Chicago, IL). Differences between groups 
in continuous variables were evaluated with Student’s T-tests or 
Mann–Whitney tests. Bivariate associations were assessed by Pearson 
correlation tests. Linear regression models were used to estimate 
mean adjusted changes in renal function per unit of BMI z-score. 
Two-sided P < 0.05 was considered significant. To evaluate the agree-
ment between methods of eGFR estimation, calculation of differences 
(means ± SD), accuracies (within 10, 30, and 50%), and absolute bias 
(i.e., average difference between eGFR and CrCl) were performed and 
Bland Altman charts were plotted.
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